Kinetics of bactericidal potency with synergistic combination of allicin and selected antibiotics

J Biosci Bioeng. 2022 Jun;133(6):567-578. doi: 10.1016/j.jbiosc.2022.02.007. Epub 2022 Mar 24.

Abstract

Synergistic therapy against the resurgence of bacterial pathogenesis is a modern trend for antibacterial chemotherapy. The phytochemical allicin, found in garlic extract is a commendable antimicrobial agent that can be used in synergistic combination with modern antibiotics. Determination of optimal antibacterial combination for the target species is vital for maximizing efficacy, lowering toxicity, total eradication of the bacterial cells and minimization of the risk of resistance generation. In this present investigation, Hill function-based pharmacodynamics models were employed to elaborate various time-kill kinetics parameters. The bactericidal potency of the synergistic combinations of allicin and individual antibiotic was assessed in comparison to their monotherapy application viz. using sole allicin and sole antibiotics (levofloxacin, ciprofloxacin, oxytetracycline, rifaximin, ornidazole and azithromycin) on actively growing Bacillus subtilis and Escherichia coli bacteria. Here, all the synergistic combinations showed significantly better (t-test p-value < 0.05) killing effect and biofilm reduction potential compared to their respective monotherapy application, where the highest killing effect was observed with rifaximin-allicin combination (kill rate was more than 5.5 h-1). Moreover, the average inhibition potential to protein denaturation by the synergistic combination group was significantly higher (3.4 fold) than the sole antibiotic's group manifests reduction in the dose-related toxicity. The potential of synergism between antibiotics and allicin combination demonstrated greater killing efficiency at significantly lower concentration compared to monotherapy with increased kill rates in all cases.

Keywords: Allicin; Biofilm; Pharmacodynamics; Synergy; Time kill.

MeSH terms

  • Anti-Bacterial Agents* / chemistry
  • Anti-Bacterial Agents* / pharmacology
  • Bacteria
  • Disulfides
  • Drug Synergism
  • Escherichia coli
  • Kinetics
  • Microbial Sensitivity Tests
  • Rifaximin / pharmacology
  • Sulfinic Acids* / pharmacology
  • Sulfinic Acids* / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Disulfides
  • Sulfinic Acids
  • allicin
  • Rifaximin